{"component": "definition", "props": {"groups": [{"snippet": "means B-Cell Maturation Antigen.", "snippet_links": [], "size": 5, "samples": [{"hash": "lPRMsjdgNAA", "uri": "/contracts/lPRMsjdgNAA#bcma", "label": "License Agreement (Bluebird Bio, Inc.)", "score": 32.603012085, "published": true}, {"hash": "dMIfQuWl8Hs", "uri": "/contracts/dMIfQuWl8Hs#bcma", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "6oeRqtGIYrI", "uri": "/contracts/6oeRqtGIYrI#bcma", "label": "License Agreement (Bluebird Bio, Inc.)", "score": 27.8364143372, "published": true}], "hash": "87690dc936ac9cc8ca4443f35ef18794", "id": 1}, {"snippet": "means B-cell maturation antigen.", "snippet_links": [], "size": 4, "samples": [{"hash": "dqFyKRlegh8", "uri": "/contracts/dqFyKRlegh8#bcma", "label": "Contingent Value Rights Agreement (Roche Holdings Inc)", "score": 36.0143737793, "published": true}, {"hash": "7P2hvS3blo2", "uri": "/contracts/7P2hvS3blo2#bcma", "label": "Agreement and Plan of Merger (Poseida Therapeutics, Inc.)", "score": 35.9021224976, "published": true}, {"hash": "aixJRiR0xsL", "uri": "/contracts/aixJRiR0xsL#bcma", "label": "Collaboration and License Agreement (Legend Biotech Corp)", "score": 31.3627643585, "published": true}], "hash": "22b5c49b881b00308178c8564810aa46", "id": 2}, {"snippet": "means the specific Antigen (or part thereof) coded for by reference to the sequence defined in Schedule 1 under the BCMA-CAR Program; \u201c[***]\u201d means [***] in which one of the [***] intended to [***] on the [***] is capable of binding to [***]; \u201c[***] Option\u201d means Autolus\u2019s rights under Clause 7; \u201c[***] Field\u201d means all uses without restriction except for use in [***];", "snippet_links": [{"key": "reference-to", "type": "clause", "offset": [58, 70]}, {"key": "schedule-1", "type": "definition", "offset": [95, 105]}, {"key": "capable-of", "type": "definition", "offset": [214, 224]}, {"key": "under-clause-7", "type": "clause", "offset": [281, 295]}], "size": 3, "samples": [{"hash": "2gqxT5fMzgT", "uri": "/contracts/2gqxT5fMzgT#bcma", "label": "License Agreement (Autolus Therapeutics LTD)", "score": 29.353181839, "published": true}, {"hash": "aY3pD9Ia1yH", "uri": "/contracts/aY3pD9Ia1yH#bcma", "label": "License Agreement (Autolus Therapeutics LTD)", "score": 29.3449687958, "published": true}], "hash": "1de1c1c27c1338679e9cbc497cf89202", "id": 3}, {"snippet": "means the receptor described in International Patent ---- Application [*].", "snippet_links": [], "size": 3, "samples": [{"hash": "2IBLeUv8B2C", "uri": "/contracts/2IBLeUv8B2C#bcma", "label": "Collaborative Development and Marketing Agreement (Zymogenetics Inc)", "score": 18.0, "published": true}], "hash": "d6bd5341408444bcdd8ca7bd283d5610", "id": 4}, {"snippet": "or the \u201cAdministrator\u201d shall mean the British Columbia Medical Association as administrator of the BCMA Health Benefits Trust Fund;", "snippet_links": [{"key": "british-columbia", "type": "clause", "offset": [38, 54]}, {"key": "trust-fund", "type": "clause", "offset": [120, 130]}], "size": 2, "samples": [{"hash": "8xZ9NATV5Xf", "uri": "/contracts/8xZ9NATV5Xf#bcma", "label": "Employer Agreement", "score": 22.8670387268, "published": true}, {"hash": "46dJdtE60ID", "uri": "/contracts/46dJdtE60ID#bcma", "label": "Employer Agreement", "score": 21.8432636261, "published": true}], "hash": "cd52323272c2c9924f2b11ca8f6e5eb3", "id": 5}, {"snippet": "means an agreement between the Company, Cowen and Chardan, entered into on or about December 7, 2017.", "snippet_links": [{"key": "agreement-between", "type": "clause", "offset": [9, 26]}, {"key": "the-company", "type": "clause", "offset": [27, 38]}, {"key": "entered-into", "type": "clause", "offset": [59, 71]}], "size": 2, "samples": [{"hash": "c1YdBnE8kx0", "uri": "/contracts/c1YdBnE8kx0#bcma", "label": "Registration Rights Agreement (Kaleyra, Inc.)", "score": 31.3381252289, "published": true}, {"hash": "dWVGNITHFhb", "uri": "/contracts/dWVGNITHFhb#bcma", "label": "Settlement Agreement (Kaleyra, Inc.)", "score": 31.3052711487, "published": true}], "hash": "c041f66b7e4082ffcbdad15c483da69f", "id": 6}, {"snippet": "means British Columbia Medical Association;", "snippet_links": [{"key": "british-columbia", "type": "clause", "offset": [6, 22]}], "size": 2, "samples": [{"hash": "dhsjDpv9tuK", "uri": "/contracts/dhsjDpv9tuK#bcma", "label": "Asset Purchase Agreement (MDS Inc)", "score": 21.0, "published": true}], "hash": "39f11572718da3159959ef5fa0b430e5", "id": 7}, {"snippet": "means B-cell maturation antigen. 1.8 \u201cBelamaf\u201d has the meaning set forth in the Recitals hereto. 1.9 \u201cBioanalytical Testing\u201d has the meaning set forth in Section 9.3. 1.10 \u201cBiomarkers\u201d mean any naturally occurring molecule, gene or characteristic by which a particular pathological or physiological process can be identified and serially monitored during a therapeutic intervention, including blood (including cells, RNA and circulating multiple myeloma cells (CMMCs)), serum (including cytokines and sBCMA), plasma (including cfDNA), tissue and tumors (including FFPE bone marrow aspirate and biopsy Samples). 1.11 \u201cBiomarker Testing\u201d has the meaning set forth in Section 9.2. 1.12 \u201cBusiness Day\u201d means any day other than (a) a Saturday, Sunday or any public holiday in Boston, Massachusetts or London, England; and (b) a day falling within the time period from and including 24 December up to and including 1 January. 1.13 \u201ccGMP\u201d means the current Good Manufacturing Practices officially published and interpreted by EMA, FDA and other applicable Regulatory Authorities that may be in effect from time to time and are applicable to the Manufacture of the Compounds. These include requirements set forth in FDA\u2019s regulations at 21 CFR Parts 11, 210, 211 and 600, as applicable to the processing, manufacture, handling, receipt, packaging, labelling, release and distribution of products and services subject to this Agreement. 1.14 \u201cChange of Control\u201d of a Party means any of the following, in a single transaction or a series of related transactions: (a) the sale or disposition of all or substantially all of the assets of such Party to a Third Party, (b) the direct or indirect acquisition by a Third Party (other than an employee benefit plan (or related trust) sponsored or maintained by such Party or any of its Affiliates) of beneficial ownership of more than fifty percent (50%) of", "snippet_links": [{"key": "the-recitals", "type": "clause", "offset": [76, 88]}, {"key": "section-93", "type": "clause", "offset": [154, 165]}, {"key": "naturally-occurring", "type": "definition", "offset": [194, 213]}, {"key": "therapeutic-intervention", "type": "definition", "offset": [357, 381]}, {"key": "bone-marrow", "type": "definition", "offset": [569, 580]}, {"key": "biomarker-testing", "type": "definition", "offset": [617, 634]}, {"key": "section-92", "type": "clause", "offset": [665, 676]}, {"key": "business-day", "type": "clause", "offset": [684, 696]}, {"key": "public-holiday", "type": "clause", "offset": [753, 767]}, {"key": "a-day", "type": "definition", "offset": [821, 826]}, {"key": "period-from", "type": "definition", "offset": [851, 862]}, {"key": "current-good-manufacturing-practices", "type": "definition", "offset": [942, 978]}, {"key": "officially-published", "type": "definition", "offset": [979, 999]}, {"key": "applicable-regulatory-authorities", "type": "definition", "offset": [1038, 1071]}, {"key": "in-effect", "type": "definition", "offset": [1084, 1093]}, {"key": "from-time-to-time", "type": "clause", "offset": [1094, 1111]}, {"key": "applicable-to", "type": "definition", "offset": [1120, 1133]}, {"key": "the-processing", "type": "clause", "offset": [1281, 1295]}, {"key": "products-and-services", "type": "clause", "offset": [1379, 1400]}, {"key": "to-this-agreement", "type": "clause", "offset": [1409, 1426]}, {"key": "change-of-control", "type": "definition", "offset": [1434, 1451]}, {"key": "a-party", "type": "clause", "offset": [1456, 1463]}, {"key": "single-transaction", "type": "clause", "offset": [1497, 1515]}, {"key": "related-transactions", "type": "definition", "offset": [1531, 1551]}, {"key": "disposition-of", "type": "clause", "offset": [1569, 1583]}, {"key": "all-or-substantially-all-of-the-assets", "type": "definition", "offset": [1584, 1622]}, {"key": "such-party", "type": "clause", "offset": [1626, 1636]}, {"key": "direct-or-indirect", "type": "clause", "offset": [1663, 1681]}, {"key": "by-a-third-party", "type": "clause", "offset": [1694, 1710]}, {"key": "employee-benefit-plan", "type": "clause", "offset": [1726, 1747]}, {"key": "related-trust", "type": "definition", "offset": [1752, 1765]}, {"key": "ownership-of", "type": "clause", "offset": [1845, 1857]}, {"key": "fifty-percent", "type": "definition", "offset": [1868, 1881]}], "size": 1, "samples": [{"hash": "1PbRtB3uJW0", "uri": "/contracts/1PbRtB3uJW0#bcma", "label": "Collaboration and License Agreement (SpringWorks Therapeutics, Inc.)", "score": 31.8377819061, "published": true}], "hash": "260636c4f6119996a5e9bc040fe4fd52", "id": 8}, {"snippet": "means the specific Antigen (or part thereof) coded for by reference to the sequence defined in Schedule 1 under the BCMA-CAR Program; CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. EXHIBIT 10.1 ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. \u00a7\u00a7 200.80(B)(4) and 230.406 \u201c[***]\u201d means [***] in which one of the [***] intended to [***] on the [***] is capable of binding to [***]; \u201c[***] Option\u201d means Autolus\u2019s rights under Clause 7; \u201c[***] Field\u201d means all uses without restriction except for use in [***]; \u201c[***] Licence\u201d has the meaning set out in Clause 2.2.2;", "snippet_links": [{"key": "reference-to", "type": "clause", "offset": [58, 70]}, {"key": "schedule-1", "type": "definition", "offset": [95, 105]}, {"key": "this-exhibit", "type": "definition", "offset": [192, 204]}, {"key": "the-information", "type": "clause", "offset": [236, 251]}, {"key": "subject-to", "type": "definition", "offset": [252, 262]}, {"key": "confidentiality-request", "type": "definition", "offset": [265, 288]}, {"key": "filed-separately-with-the-securities-and-exchange-commission", "type": "clause", "offset": [366, 426]}, {"key": "confidential-treatment-requested", "type": "definition", "offset": [478, 510]}, {"key": "capable-of", "type": "definition", "offset": [635, 645]}, {"key": "under-clause-7", "type": "clause", "offset": [702, 716]}, {"key": "set-out", "type": "definition", "offset": [824, 831]}, {"key": "in-clause", "type": "clause", "offset": [832, 841]}], "size": 1, "samples": [{"hash": "9WM28JkksYm", "uri": "/contracts/9WM28JkksYm#bcma", "label": "License Agreement", "score": 31.3408622742, "published": true}], "hash": "a1d5ddbba79f48e89b848d4b24026575", "id": 9}, {"snippet": "means the specific Antigen (or part thereof) coded for by reference to the sequence defined in Schedule 1 under the BCMA-CAR Program;", "snippet_links": [{"key": "reference-to", "type": "clause", "offset": [58, 70]}, {"key": "schedule-1", "type": "definition", "offset": [95, 105]}], "size": 1, "samples": [{"hash": "ddBGOR5C9Ag", "uri": "https://www.sec.gov/Archives/edgar/data/1730463/000119312521203817/d196189dex991.htm", "label": "Autolus Therapeutics PLC", "score": 16.4934978485, "published": false}], "hash": "536d84331e1951ebfbecaeb6400d9e4a", "id": 10}], "next_curs": "ClESS2oVc35sYXdpbnNpZGVyY29udHJhY3Rzci0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiINYmNtYSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means B-Cell Maturation Antigen.", "size": 28, "title": "BCMA", "id": "bcma", "examples": ["The <strong>BCMA</strong> will not condone or support a withdrawal of services contrary to the guidance provided by the College of Physicians and Surgeons of British Columbia.", "If the Government and the <strong>BCMA</strong> are unable to agree upon the chair of the conciliation panel either of them may request the Chief Justice of the Supreme Court of British Columbia to make the appointment and the individual so appointed will be the chair of the conciliation panel.", "On receipt of the Direct Licence from CRUK, Autolus shall be entitled to deduct an amount equivalent to any sums Autolus pays CRUK under the Direct Licence from any amount Autolus is due to pay UCLB with respect to the GD2 Product, the TRBC1/2 Product (including the [***]) and the <strong>BCMA</strong> Product.", "Functional Ability Forms (FAF) requested by the Employer, will be paid by the Employer in accordance with the <strong>BCMA</strong> fee guide.", "For the purposes of this Clause, \u201cCRUK Rights\u201d shall mean those parts of the licences hereunder to Autolus where (i) CRT is the head licensor to UCLB which includes the GD2 Clinical Study Results and the [***]; or (ii) the CRUK Funders have directly funded the development of the licensed Intellectual Property being certain of the <strong>BCMA</strong> Program IP.", "When such concerns arise the Government and the <strong>BCMA</strong> will form task forces to work together to attempt to relieve such concerns.", "The <strong>BCMA</strong> will take all appropriate measures to encourage physicians to comply with applicable agreements once they are ratified and concluded.", "The Commission will give the <strong>BCMA</strong> written notice when the Commission&#x27;s projections indicate that the Available Amount will be exceeded immediately after such a projection is accepted by the Commission.", "The <strong>BCMA</strong> will take all appropriate measures to encourage physicians to comply with existing agreements.", "The Government and the <strong>BCMA</strong> will pay the costs of the participation in the Joint Agreement Administration Group of their respective appointees."], "related": [["ccma", "CCMA", "CCMA"], ["omha", "OMHA", "OMHA"], ["cma", "CMA", "CMA"], ["cja", "CJA", "CJA"], ["nofa", "NOFA", "NOFA"]], "related_snippets": [], "updated": "2025-08-09T06:18:10+00:00"}, "json": true, "cursor": ""}}